Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pharmaceutical

The 4 Best Forever Stocks to Buy in February 2023

The stock market volatility is not expected to end anytime soon as the macroeconomic headwinds remain. So, I think fundamentally solid Johnson & Johnson (JNJ), Gilead Sciences (GILD), Stellantis (STLA), and Cardinal Health (CAH) could be the best stocks to own now and forever. Keep reading.

StockNews.com

3 Top Stocks You Can Buy Now and Hold for a Lifetime

With the central bank’s progress in controlling inflation, recession risks have subsided. Amid early signs of resilience, the IMF recently upgraded the outlook for the U.S. economy in 2023. Given this backdrop, fundamentally strong stocks Halliburton (HAL), Cardinal Health (CAH), and Jabil (JBL) could be ideal buy-and-hold options for solid…

StockNews.com

3 Top Pharma Stocks to Buy for the Long Haul

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Stocks to Buy Now and Hold for the Long Term

As the Fed hinted at raising interest rates through 2023, investors are worried about a recession. However, the rate hike aggression is expected to slow down if inflation keeps cooling. Regardless of market conditions, buying and holding fundamentally sound stocks Johnson & Johnson (JNJ), Berry Corporation (BRY), Honda Motor Company…

StockNews.com

4 Pharmaceutical Stocks You Can Always Rely On

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

StockNews.com

4 Stocks That Can Weather Any Market Storm

Persistently high inflation and the Federal Reserve’s hawkish stance to handle it has resulted in significant market volatility this year. Moreover, experts amplified their warnings of a recession next year. Given the uncertain market backdrop, it could be wise to invest in fundamentally sound and resilient stocks, Johnson & Johnson…

StockNews.com

Abiomed Stock Soars After $16.6 Billion Johnson & Johnson Takeover Amid Deeper Medical Devices Push

"The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato.

The Street

Read news from The Economist, FT, and more,
with one subscription

2 Pharmaceutical Stocks That Could Outperform the Market in the Long Term

The pharmaceutical industry is growing rapidly with advancements in drug manufacturing and a paradigm shift to personalized medicines. Moreover, despite soaring prices, supportive fiscal policies are expected to keep consumer demand stable. Quality pharmaceutical stocks Pfizer (PFE) and Merck (MRK) have outperformed the broader market over the past year and…

StockNews.com

4 Pharmaceutical Stocks with Tremendous Growth Potential

The global pharmaceutical industry has witnessed robust growth over the past few years. The rapidly aging population and continued breakthroughs in drug development are expected to keep driving the industry’s growth. Thus, we think pharmaceutical stocks Assertio Holdings (ASRT), Bayer (BAYRY), Eagle Pharmaceuticals (EGRX), and Merck (MRK), which possess solid…

StockNews.com

3 Drug Manufacturers to Buy on the Pullback

The global pharmaceutical industry is expected to thrive with the lingering impact of COVID-19 and the evolving healthcare landscape. Given the industry’s solid prospects, the pullbacks in drug manufacturing stocks Merck & Co (MRK), Bristol-Myers Squibb (BMY), and Bayer Aktiengesellschaft (BAYRY) amid the broader market correction preset solid buying opportunity.…

StockNews.com

Bargain-Hunting: 3 Mega-Cap Pharmaceutical Stocks to Buy and Hold

Although the heightened market volatility has caused several pharma stocks to slump in price, the sector’s long-term prospects look bright. This sector has been attracting massive investments and could remain in the limelight in the near term. So, we think it should be wise to buy and hold mega-cap pharmaceutical…

StockNews.com

5 Resilient Stocks to Buy for a Market Downturn

Yesterday, the broad market indices closed in negative territory on interest-rate-increase concerns. Goldman Sachs has predicted that the S&P might tumble to 3,600 this year if recessionary pressure persists. Non-cyclical stocks usually perform well during economic downturns. So, we believe Cardinal Health (CAH), Brookfield Infrastructure Corp. (BIPC), Smith & Nephew…

StockNews.com

3 Pharmaceutical Stocks to Buy for the Long-Term

The global pharmaceutical industry is expected to witness stable growth over the long term, owing to the rising medical needs of an aging population and consistent innovations in the treatment of chronic ailments. So, we think it could be wise to scoop up shares of quality pharmaceutical stocks Johnson &…

StockNews.com

1 2

People

Joaquin Duato

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.